Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fujisaka

Showing results (71-80 of 252) with videos related to

Pageof 26
Sort By:
Japanese Journal of Clinical Oncology|November 11, 2006
Phase 1 clinical study of pegylated liposomal doxorubicin (JNS002) in Japanese patients with solid tumorsYasuhito Fujisaka, Atsushi Horiike, Toshio Shimizu, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|October 9, 2003
[Pulmonary septic emboli in a patient with right-side infectious endocarditis]Hirokazu Taniguchi, Shiho Fujisaka, Hitoshi Abo, et al.
International Heart Journal|November 12, 2025
Clinical Implications of a Nurse-Led Heart Failure Clinic at a Rural Japanese HospitalHiroshi Miyashita, Teruhiko Imamura, Tomomi Tanaka, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2007
Phase I dose-finding and pharmacokinetic study of the oral epidermal growth factor receptor tyrosine kinase inhibitor Ro50-8231 (erlotinib) in Japanese patients with solid tumorsNoboru Yamamoto, Atsushi Horiike, Yasuhito Fujisaka, et al.
Journal of Atherosclerosis and Thrombosis|November 17, 2012
Plaque-stabilizing effect of angiotensin-converting enzyme inhibitor and/or angiotensin receptor blocker in a rabbit plaque modelJunko Hotchi, Masaaki Hoshiga, Yoshihiro Takeda, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|December 24, 2005
Epidemiologic characteristics of definite Ménière's disease in Japan. A long-term survey of Toyama and Niigata prefecturesHideo Shojaku, Yukio Watanabe, Michiro Fujisaka, et al.
Modern Rheumatology|May 22, 2026
The evolutionary trade-off between immunosurveillance and self-tolerance: Insights from four rheumatologic themesMasaru Kato, Masatoshi Kawataka, Satoshi Yamaguchi, et al.
International Journal of Clinical Oncology|June 4, 2025
Guidance on the short hydration method for cisplatin administrationKiichiro Ninomiya, Kei Kunimasa, Yasuko Kurata, et al.
Japanese Journal of Clinical Oncology|March 6, 2009
Phase I and pharmacokinetic study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese patients with solid tumorsNoboru Yamamoto, Yasuhide Yamada, Yutaka Fujiwara, et al.
Chemical & Pharmaceutical Bulletin|June 2, 2024
Viscosity-Induced Emission of 5-(Diarylmethylene)imidazolone with Extended Conjugation via Attachment of N-Methylpyrrole at the 2-PositionMasahiro Ikejiri, Aki Yoshimizu, Fumika Shiota, et al.
Pageof 26

Showing results (71-80 of 252) with videos related to

Sort By:
Pageof 26
Japanese Journal of Clinical Oncology|November 11, 2006
Phase 1 clinical study of pegylated liposomal doxorubicin (JNS002) in Japanese patients with solid tumorsYasuhito Fujisaka, Atsushi Horiike, Toshio Shimizu, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|October 9, 2003
[Pulmonary septic emboli in a patient with right-side infectious endocarditis]Hirokazu Taniguchi, Shiho Fujisaka, Hitoshi Abo, et al.
International Heart Journal|November 12, 2025
Clinical Implications of a Nurse-Led Heart Failure Clinic at a Rural Japanese HospitalHiroshi Miyashita, Teruhiko Imamura, Tomomi Tanaka, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2007
Phase I dose-finding and pharmacokinetic study of the oral epidermal growth factor receptor tyrosine kinase inhibitor Ro50-8231 (erlotinib) in Japanese patients with solid tumorsNoboru Yamamoto, Atsushi Horiike, Yasuhito Fujisaka, et al.
Journal of Atherosclerosis and Thrombosis|November 17, 2012
Plaque-stabilizing effect of angiotensin-converting enzyme inhibitor and/or angiotensin receptor blocker in a rabbit plaque modelJunko Hotchi, Masaaki Hoshiga, Yoshihiro Takeda, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|December 24, 2005
Epidemiologic characteristics of definite Ménière's disease in Japan. A long-term survey of Toyama and Niigata prefecturesHideo Shojaku, Yukio Watanabe, Michiro Fujisaka, et al.
Modern Rheumatology|May 22, 2026
The evolutionary trade-off between immunosurveillance and self-tolerance: Insights from four rheumatologic themesMasaru Kato, Masatoshi Kawataka, Satoshi Yamaguchi, et al.
International Journal of Clinical Oncology|June 4, 2025
Guidance on the short hydration method for cisplatin administrationKiichiro Ninomiya, Kei Kunimasa, Yasuko Kurata, et al.
Japanese Journal of Clinical Oncology|March 6, 2009
Phase I and pharmacokinetic study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese patients with solid tumorsNoboru Yamamoto, Yasuhide Yamada, Yutaka Fujiwara, et al.
Chemical & Pharmaceutical Bulletin|June 2, 2024
Viscosity-Induced Emission of 5-(Diarylmethylene)imidazolone with Extended Conjugation via Attachment of N-Methylpyrrole at the 2-PositionMasahiro Ikejiri, Aki Yoshimizu, Fumika Shiota, et al.
Pageof 26